Anxiolytic activity of Vitex negundo Linn. in experimental models of anxiety in mice
DOI:
https://doi.org/10.22377/ijgp.v3i3.93Abstract
The purpose of this study was to characterize the putative anxiolytic-like activity of an ethanolic extract prepared from the roots of Vitex negundo (VN) using the elevated plus maze (EPM) and light–dark exploration test in mice. Male mice were either treated orally with the VN extract or the positive control diazepam, respectively, 1 hour before behavioral evaluation. Oral administration of 100 and 200 mg/kg of VN extract significantly (P > 0.01) increased the percentage time spent on and the number of entries into the openarms of the EPM. The effect was comparable to that of the benzodiazepine diazepam (2 mg/kg p.o.). In light–dark exploration test, diazepam-treated rats significantly increased the time spent in light arena and decreased the duration of immobility, while VN treated rats also showed a significant (P >0.01) increase in the time spent (100 and 200 mg/kg) in light arena. Diazepam and the VN extracts do not produced any overt motor dysfunction. These results indicate that VN is an effective anxiolytic agent. In conclusion, the action of extract upon the anxiety models tested are in accord with the traditional use of VN L. and could be useful in primary medical care.
Key words: Vitex negundo, anxiolytic, elevated plus maze, light–dark exploration, locomotor activity
Downloads
References
Barar FSK. Essentials of Pharmacotheraupetics. New Delhi: S.
Chand and Company Ltd; 2005. p. 89.
Eisenberg RB, Davis SL, Ettner S, Appel S, Wilkey M, Rompay V,
et al. Trends in alternative medicine used in United States: Results
of a follow up national survey. J Am Med Assoc 1998;280:1569-75.
Vogel HG, Vogel WH. Drug discovery and evaluation. Heidelberg,
Springer, New York: 2002. p. 401.
Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and
Pharmacotheraupetics. 19th ed. Mumbai: Popular Prakashan;
p. 198.
Griffiths RR, Sannerud CA. Abuse of and dependence
on Benzodiazepines and Other axiolytic/sedative Drugs.
Psychopharmacology Services. 3rd ed. New York: Raven Press;
p. 1535-40.
Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of
triazolam: experimental measurements in animals and humans.
Psychopharmacological Services. 3rd ed. New York: Raven Press;
. 83-7.
Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible
anxiolytic effects of chrysin: A central benzodiazepine receptor
ligand isolated from Passiflora coerulea. Pharmacol Biochem
Behav 1994;47:1-4.
Viola H, Stein ML de, Wolfman C. Apigenin. A component of
Matricaria recutita flowers, is a central benzodiazepine receptorligand
with anxiolytic effects. Planta Med 1996;61:213-6.
Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina
JH. Anxiolytic natural and synthetic flavonoid ligands of the
central benzodiazepine receptor have no effect on memory tasks
in rats. Pharmacol Biochem Behav 1997;58:887-91.
Paladini C, Marder M, Viola H, Wolfman C, Wasowski C, Medina
JH. Flavonoids and the central nervous system: From forgotten
factors to potent anxiolytic compounds. J Pharmacy Pharmacol
;51:519-26.
Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine
dependence in mice by a tri-substituted benzoflavone moiety of
Passiflora incarnata Linneaus: A non-habit forming anxiolytic. J
Pharma Pharma Sci 2003;6:215-22.
Heinrich M, Gibbons S. Ethanopharmacology in drug discovery:
An analysis of its role and potential contribution. J Pharmacy
Pharmacol 53:425-32.
Beaubrum G, Gray GE. A review of herbal medicines for
psychiatric disorders. Psychiatr Serv 2000;51:1130-4.
Rex A, Morgenster E, Fink H. Anxiolytic-like effects of kava-kava
in the elevated plus maze test-comparison with diazepam. Progr
Neuro-Psychopharmacol Biol Psychaitry 2002;26:855-60.
Friede M, Freudenstein J. Antidepressant and Anxiolytic Effect of
St. John’s Wort Extract ZE-117. Eur Psychaitry 2002;17:96.
Une HD, Sarveiya VP, Pal SC, Kasture VS, Kasture SB. Nootropic
and Anxiolytic Activity of Saponins from Albizzia Lebbeck leaves.
Pharmacol Biochem Behav 2001;69:439-44.
Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, et al.
Steaming of ginseng at high temperature enhances biological
activity. J Nat Prod 2000;63:1702-4.
Anonymous. Directory of Indian Medicinal Plants. Lucknow:
CIMAP; 1992. p. 49.
Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Delhi:
Periodicals Experts Book Agency; 1991.
Wealth of India. New Delhi: Publication and Information, Council
of Scientific and Industrial; 1976. p. 522.
Chawla S, Sharma AK, Handa SS, Dhar KL. Chemical investigation
and anti-inflammatory activity of Vitex negundo seeds: Part I. Indian
J Chem 1991;30:773-6.
Chawla S, Sharma AK, Handa SS. Chemical investigation and
anti-inflammatory activity of Vitex negundo seeds: Part II. J Nat
Products 1992;55:163-7.
Srivastava SC, Sisodia CS. Analgesic studies on Vitex negundo and
Valeriana wallichii. Indian Veterinary J 1970;47:170-5.
Telang RS, Chatterjee S, Varshneya C. Studies on analgesic and antiinflammatory
activities of Vitex Negundo Linn. Indian J Pharmacol
;31:363-6.
Gupta M, Majumdar UK, Bhawal SR, Swami SMK. CNS activity
of petroleum ether extract of Vitex negundo Linn in mice. Indian J
Pharm Sci 1997;59:240-5.
Tamhankar P, Saraf MN. Antiarthritic activity of Vitex negundo
Linn. Indian J Pharm Sci 1994;56:158-61.
Nair M, Rajagopalan V, Saraf MN. Antiallergic activity of Vitex
negundo Linn. Chandigarh: Paper presented at the 46th Indian
Pharmaceutical Congress; 1994.
Nair M. Studies on the antiallergic activity of Vitex negundo Linn.
A thesis submitted to the University of Bombay for the M.Pharm
degree 1994.
Nair M, Tamhankar CP, Saraf MN. Studies on the mast cell stabilising
activity of Vitex negundo Linn. Indian Drugs 1995;32:277-82.
Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS,
Ratnasooriya WD. Anti-inflammatory and analgesic activities
of mature fresh leaves of Vitex negundo. J Ethnopharmacol
;87:199-206.
Tandon VR, Gupta RK. An experimental evaluation of
anticonvulsant activity of Vitex negundo. Indian J Physiol Phamocol
;49:199-205.
Tandon V, Gupta RK. Vitex negundo Linn (VN) leaf extract as an
adjuvant therapy to standard anti-inflammatory drugs. Indian J
Med Res 2006;124:447-50.
Kulkarni SK, Reddy DS. Animal behavioral models for testing antianxiety
activity. Met Finds Exp Clin Pharmacol 1996;18:219–40.
Vogel HG, Vogel WHO. Drug Discovery and Evaluation. Germany:
Heidelberg, Springer; 1997. p. 378–9.
Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ.
Zacopride: Anxiolytic profile in rodent and primate models of
anxiety. J Pharmacy Pharmacol 1988;40:302-5.
Crawley JN, Goodwin FK. Neuropharmacologic specificity of a
simple animal model for the behavioral actions of benzodiazepines.
Pharmacol Biochem Behav 1981;15:595-9.
Amborgi LC, Giachetti A. Some factors influencing conditioned
and spontaneous behaviour of rats in the light-dark box test.
Physiol Behav 1986;36:97-101.
Kulkarni SK. Handbook of experimental pharmacology. 3rd ed.
New Delhi: Vallabh Prakashan 2005. p. 117-9.
Dawson GR, Tricklebank MD. Use of the elevated plus maze
in search for novel anxiolytic agents. Trends Pharmacol Sci
;16:33-6.
Soderpalm R, Hjorth S, Engel JA. Effects of 5-HTA Receptor
agonists and L-5-HTP in montgomery’s conflict test. Pharmacol
Biochem Behav 1989;32:259-65.
Treit D. Animal models for the study of anti-anxiety agents: A
review. Neurosci Biobehav Rev 1985;9:203-22.
Lewis JJ. An introduction to pharmacology. London: E. S.
Livingstone; 1980. p. 287.
Ha JH, Lee DU, Lee JT. 4-hydroxy benzaldehyde from Gasrtrodia
elata as active in the antioxidation and GABA ergic neuromodulation
of the rat brain. J Ethnopharmacol 2000;73:329-33.
